SI1003496T1 - Medicament for treating prostate intraepithelial neoplasia - Google Patents

Medicament for treating prostate intraepithelial neoplasia

Info

Publication number
SI1003496T1
SI1003496T1 SI9930740T SI9930740T SI1003496T1 SI 1003496 T1 SI1003496 T1 SI 1003496T1 SI 9930740 T SI9930740 T SI 9930740T SI 9930740 T SI9930740 T SI 9930740T SI 1003496 T1 SI1003496 T1 SI 1003496T1
Authority
SI
Slovenia
Prior art keywords
intraepithelial neoplasia
medicament
prostate intraepithelial
treating prostate
treating
Prior art date
Application number
SI9930740T
Other languages
English (en)
Slovenian (sl)
Inventor
Mitchell S. Steiner
Sharon Raghow
Original Assignee
The University Of Tennessee Research Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University Of Tennessee Research Corporation filed Critical The University Of Tennessee Research Corporation
Publication of SI1003496T1 publication Critical patent/SI1003496T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI9930740T 1998-05-07 1999-05-07 Medicament for treating prostate intraepithelial neoplasia SI1003496T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8460298P 1998-05-07 1998-05-07
EP99924157A EP1003496B1 (en) 1998-05-07 1999-05-07 Medicament for treating prostate intraepithelial neoplasia
PCT/US1999/010146 WO1999056739A1 (en) 1998-05-07 1999-05-07 A method for chemoprevention of prostate cancer

Publications (1)

Publication Number Publication Date
SI1003496T1 true SI1003496T1 (en) 2005-10-31

Family

ID=22186034

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930740T SI1003496T1 (en) 1998-05-07 1999-05-07 Medicament for treating prostate intraepithelial neoplasia

Country Status (26)

Country Link
US (1) US6265448B1 (cs)
EP (3) EP2277514A1 (cs)
JP (2) JP4482229B2 (cs)
AT (1) ATE283043T1 (cs)
AU (1) AU761435B2 (cs)
BG (1) BG65597B1 (cs)
CA (1) CA2323809C (cs)
CZ (1) CZ300960B6 (cs)
DE (2) DE69922131T2 (cs)
DK (1) DK1003496T3 (cs)
EA (1) EA003466B1 (cs)
ES (1) ES2145730T3 (cs)
HR (1) HRP20000729A2 (cs)
HU (1) HUP0102068A3 (cs)
IL (3) IL138437A0 (cs)
IS (2) IS2213B (cs)
NO (1) NO20005625L (cs)
NZ (1) NZ527522A (cs)
PL (1) PL207462B1 (cs)
PT (1) PT1003496E (cs)
SI (1) SI1003496T1 (cs)
SK (1) SK16642000A3 (cs)
TR (1) TR200003269T2 (cs)
UA (1) UA74532C2 (cs)
WO (1) WO1999056739A1 (cs)
YU (1) YU68600A (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040186185A1 (en) * 1998-05-07 2004-09-23 Steiner Mitchell S. Method for treatment and chemoprevention of prostate cancer
US20040092602A1 (en) * 1998-05-07 2004-05-13 Steiner Mitchell S. Method for treatment and chemoprevention of prostate cancer
SK16642000A3 (sk) * 1998-05-07 2002-08-06 The University Of Tennessee Research Corporation Spôsob chemoprevencie rakoviny prostaty
US20030130316A1 (en) * 2000-03-20 2003-07-10 Steiner Mitchell S. Method for chemoprevention of prostate cancer
US6413533B1 (en) * 1998-05-07 2002-07-02 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
US6410043B1 (en) * 1998-05-07 2002-06-25 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
US6642274B1 (en) 1999-09-09 2003-11-04 Gary W. Neal Methods and compositions for preventing and treating prostate disorders
WO2001017479A2 (en) * 1999-09-09 2001-03-15 Androsolutions, Inc. Methods and compositions for preventing and treating prostate disorders
US20060269611A1 (en) * 2001-11-29 2006-11-30 Steiner Mitchell S Prevention and treatment of androgen-deprivation induced osteoporosis
US7524866B2 (en) * 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
US20040213841A1 (en) * 2001-11-29 2004-10-28 Steiner Mitchell S Methods for treating hot flashes and gynecomastia
US20040214898A1 (en) * 2001-11-29 2004-10-28 Steiner Mitchell S. Methods for treating hot flashes
DK1666033T3 (da) 2001-11-29 2009-04-06 Gtx Inc Forebyggelse og behandling af ved androgenmangel fremkaldt osteoporose
US20050080143A1 (en) * 2001-11-29 2005-04-14 Steiner Mitchell S. Treatment of androgen-deprivation induced osteoporosis
US20080249183A1 (en) * 2001-11-29 2008-10-09 Steiner Mitchell S Treatment of androgen-deprivation induced osteoporosis
US20040096510A1 (en) * 2001-11-29 2004-05-20 Steiner Mitchell S. Prevention and treatment of androgen-deprivation induced osteoporosis
US20070197664A1 (en) * 2001-11-29 2007-08-23 Steiner Mitchell S Prevention and treatment of androgen-deprivation induced osteoporosis
US7332525B2 (en) * 2003-01-17 2008-02-19 Castle Erik P Method of treatment of prostate cancer and composition for treatment thereof
US7070816B2 (en) * 2003-12-05 2006-07-04 New Chapter, Inc. Methods for treating prostatic intraepithelial neoplasia with herbal compositions
US20050208159A1 (en) * 2004-03-16 2005-09-22 Kang Kyung S Phytoestrogenic composition comprising an extract of chinese licorice root, liquiritin or isoliquiritin
US20060019989A1 (en) * 2004-07-21 2006-01-26 Steiner Mitchell S Compositions comprising 5-alpha reductase inhibitors and SERMs and methods of use thereof
WO2006052922A2 (en) * 2004-11-08 2006-05-18 Eastman Chemical Company Pharmaceutical formulations of cyclodextrins and selective estrogen receptor modulator compounds
WO2006052921A2 (en) * 2004-11-08 2006-05-18 Eastman Chemical Company Cyclodextrin solubilizers for liquid and semi-solid formulations
US20060270641A1 (en) * 2005-05-31 2006-11-30 Steiner Mitchell S Method for chemoprevention of prostate cancer
USD969722S1 (en) 2021-09-28 2022-11-15 Wagner Delima Stabilizing wedge pad

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329364A (en) 1974-09-11 1982-05-11 Schering Corporation Antiandrogenic agents and methods for the treatment of androgen dependent disease states
US4474813A (en) 1980-10-24 1984-10-02 Schering Corporation Pharmaceutical preparations comprising flutamide
FI77839C (fi) * 1982-05-27 1989-05-10 Farmos Oy Foerfarande foer framstaellning av nya terapeutiskt effektiva trifenylalkan- och alkenderivat.
GB2126576B (en) 1982-06-25 1985-06-19 Farmos Group Limited Alkane and alkene derivatives
US5491173A (en) 1982-06-25 1996-02-13 Orion-Yhtyma Oy Tri-phenyl alkene derivatives and their preparation and use
US5595985A (en) 1989-03-10 1997-01-21 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
US4990538A (en) 1989-08-23 1991-02-05 Harris Adrian L Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs
GB9126209D0 (en) 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
GB9207437D0 (en) 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites
US5847007A (en) 1993-05-13 1998-12-08 Neorx Corporation Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
CA2150714C (en) * 1992-12-01 2002-02-05 Anni Maija Warri Syndecan stimulation of cellular differentiation
US5595722A (en) 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
JPH09501174A (ja) 1993-08-09 1997-02-04 バラル、エドワード キラー細胞媒介細胞融解に対するガン細胞の増感方法
US5650425A (en) 1994-04-04 1997-07-22 Pharmos Corporation Permanently ionic derivatives of steroid hormones and their antagonists
US5635197A (en) 1995-03-21 1997-06-03 Eli Lilly And Company Treatment and prevention of prostatic cancer metastasis
US5629007A (en) 1995-03-21 1997-05-13 Eli Lilly And Company Method of preventing prostatic cancer development
ZA984650B (en) * 1997-06-19 1998-12-08 Orion Corp Intratumoral administration of triphenylethylenes for the treatment of cancer
SK16642000A3 (sk) * 1998-05-07 2002-08-06 The University Of Tennessee Research Corporation Spôsob chemoprevencie rakoviny prostaty

Also Published As

Publication number Publication date
EP1003496B1 (en) 2004-11-24
WO1999056739A1 (en) 1999-11-11
ES2145730T1 (es) 2000-07-16
IL138437A0 (en) 2001-10-31
DE1003496T1 (de) 2000-11-02
ES2145730T3 (es) 2005-06-16
PL207462B1 (pl) 2010-12-31
JP2002513755A (ja) 2002-05-14
HUP0102068A2 (hu) 2002-05-29
HRP20000729A2 (en) 2001-06-30
NZ527522A (en) 2005-04-29
NO20005625L (no) 2001-01-05
CA2323809A1 (en) 1999-11-11
PT1003496E (pt) 2005-04-29
NO20005625D0 (no) 2000-11-07
CA2323809C (en) 2007-09-18
IS8354A (is) 2006-03-15
ATE283043T1 (de) 2004-12-15
DK1003496T3 (da) 2005-04-04
SK16642000A3 (sk) 2002-08-06
EP2277514A1 (en) 2011-01-26
DE69922131T2 (de) 2005-11-24
YU68600A (sh) 2003-12-31
EA003466B1 (ru) 2003-06-26
CZ300960B6 (cs) 2009-09-23
UA74532C2 (en) 2006-01-16
JP2008163048A (ja) 2008-07-17
EA200000100A1 (ru) 2000-08-28
IL193231A0 (en) 2009-02-11
IS5700A (is) 2000-11-01
IS2213B (is) 2007-03-15
US6265448B1 (en) 2001-07-24
HUP0102068A3 (en) 2002-11-28
IL138437A (en) 2008-12-29
AU4072699A (en) 1999-11-23
JP4482229B2 (ja) 2010-06-16
TR200003269T2 (tr) 2001-02-21
CZ20004118A3 (cs) 2002-07-17
EP1475087A3 (en) 2007-07-11
BG65597B1 (bg) 2009-02-27
EP1475087A2 (en) 2004-11-10
AU761435B2 (en) 2003-06-05
DE69922131D1 (de) 2004-12-30
BG105022A (bg) 2001-07-31
PL344000A1 (en) 2001-09-10
EP1003496A1 (en) 2000-05-31

Similar Documents

Publication Publication Date Title
IL193231A0 (en) Medicament for treating prostate intraepithelial neoplasia
BR9806118A (pt) Processos para tratamento de pigmentação de pele
WO1999043355A3 (en) Formulations containing oxaliplatin
WO2000038718A3 (en) Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
WO2002018327A3 (en) Guanidinobenzamides as mc4-r agonists
AU3632497A (en) Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
WO2001024763A3 (en) Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
AU2471601A (en) A medicinal aerosol formulation
WO2001066103A3 (en) Treatment of neoplasms by inhalation of carboplatin
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
WO2002076499A3 (en) Combination treatment of pancreatic cancer
MXPA97002401A (es) Agente antiinflamatorio para uso externo.
HU911928D0 (en) Process for the production of chelates and its complexes containing orto ligating functional group, and the medical preparations containing thereof
PT1102586E (pt) Utilizacao de extractos de ginkgo biloba para a preparacao de um medicamento para o tratamento da esclerose lateral amiotrofica
MXPA02005045A (es) Preparaciones farmaceuticas que contiene agentes citostaticos y aceptores de electrones para el tratamiento de cancer.
ATE222118T1 (de) Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate
AP1896A (en) The method of treating cancer
AU3919001A (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
WO2001043705A3 (en) Compositions containing a retinoid and a stilbene for skin care
WO1999056697A3 (en) Pharmaceutical composition
MD980129A (en) Antiherpetic remedy
WO2002082866A3 (en) U-shaped discharge lamp and irradiation handpiece
BG104692A (en) Extended release tiagabine formulation
AU2002220654A1 (en) Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders
MX9709941A (es) Nueva composicion farmaceutica con efecto anestesico.